Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:05 AM UTC
| NCT Number | NCT07076407 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE3 |
| Target Enrollment | 450 participants |
| Active Locations | 35 sites in the US |
| Sponsor | Xenon Pharmaceuticals Inc. |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 18, 2026: Clinical trial NCT07076407 is currently recruiting participants. This phase3 study for major depressive disorder is actively seeking new participants at 35 locations across the United States. The study is sponsored by Xenon Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07076407 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07076407 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.